Sonion Announces New CEO & President: Niels Svenningsen

Niels Svenningsen to Further Develop Sonion's Position in the Current Market and Develop New Product

Sonion today announces the appointment of Niels Svenningsen as CEO & President of the Sonion Group. Niels Svenningsen was most recently President of Northern Europe in Schneider Electric and brings a wealth of commercial and management experience acquired in the IT and technology sectors. He will start in his new position on March 1st, 2020.

“We look very much forward to welcoming Niels. He brings an extensive commercial and general management experience to Sonion. We expect Niels to further develop our strong position of Sonion in the current market and develop new products to serve the potential of adjacent markets.” says Walther Thygesen, Chairman of the Sonion Board.

Niels Svenningsen (55 years old) was President of Northern Europe in Schneider Electric (2015-2019) and before that CEO of GN NetCom (2013-2015). Niels also has extensive experience with Sales and Marketing from large IT companies such as Hitachi Data Systems (2007-2013; Senior Vice President & General Manager EMEA 2011-2013), Hewlett Packard (Managing Director, Enterprise & Major Accounts 2002-2004; Sales Director 1996-2000) and IBM Denmark (1988-1996).

”I am very happy to be joining Sonion. This is a global company, well run and with a lot of potential, operating in an attractive market for high-tech medical components. I look forward to – together with the Sonion management team – taking Sonion further on its growth journey and exploring new attractive opportunities on the market.” says Niels Svenningsen.

Sonion is a global leader in the development and manufacturing of micro acoustic and micro mechanical solutions for hearing instruments, high-end hearables, and in-ear earphones. Sonion is owned by Novo Holdings A/S, the holding company within the Novo Group that manages the assets of the Novo Nordisk Foundation.

SourceSonion

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.